Vantis Vascular Receives FDA Clearance for 6F CrossFAST Model
New 6 French model accommodates a broader range of devices while maintaining the integrated design and deliverability of CrossFAST SAN JOSE, Calif., Oct. 13, 2026 /PRNewswire/ -- Vantis Vascular, a medical technology company developing innovative devices for vascular interventions, today...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.